Swiss National Bank Intra Cellular Therapies, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Swiss National Bank holds 185,500 shares of ITCI stock, worth $16.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

185,500

Previous 171,600 8.1%

Holding current value

$16.1 Million

Previous $11.8 Million 15.41%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$67.99 - $80.84 $945,060 - $1.12 Million	13,900 Added 8.1%	185,500 $13.6 Million
Q2 2024 Aug 08, 2024	BUY	$64.76 - $79.84 $45,332 - $55,888	700 Added 0.41%	171,600 $11.8 Million
Q1 2024 May 07, 2024	BUY	$64.37 - $75.65 $32,185 - $37,825	500 Added 0.29%	170,900 $11.8 Million
Q4 2023 Feb 06, 2024	SELL	$46.37 - $73.65 $899,578 - $1.43 Million	-19,400 Reduced 10.22%	170,400 $12.2 Million
Q3 2023 Nov 08, 2023	BUY	$52.09 - $64.1 $161,479 - $198,709	3,100 Added 1.66%	189,800 $9.89 Million
Q2 2023 Aug 09, 2023	BUY	$54.67 - $66.44 $153,076 - $186,032	2,800 Added 1.52%	186,700 $11.8 Million
Q1 2023 May 10, 2023	SELL	$43.8 - $56.99 $932,939 - $1.21 Million	-21,300 Reduced 10.38%	183,900 $9.96 Million
Q4 2022 Feb 08, 2023	BUY	$44.07 - $54.45 $171,873 - $212,355	3,900 Added 1.94%	205,200 $10.9 Million
Q3 2022 Nov 09, 2022	BUY	$42.7 - $59.99 $234,850 - $329,945	5,500 Added 2.81%	201,300 $9.37 Million
Q2 2022 Aug 09, 2022	BUY	$43.0 - $65.64 $94,600 - $144,408	2,200 Added 1.14%	195,800 $11.2 Million
Q1 2022 May 09, 2022	BUY	$38.74 - $62.09 $1.61 Million - $2.58 Million	41,500 Added 27.28%	193,600 $11.8 Million
Q4 2021 Feb 08, 2022	SELL	$35.2 - $53.42 $14,080 - $21,368	-400 Reduced 0.26%	152,100 $7.96 Million
Q3 2021 Nov 08, 2021	BUY	$28.72 - $42.49 $25,848 - $38,241	900 Added 0.59%	152,500 $5.69 Million
Q2 2021 Aug 06, 2021	SELL	$29.3 - $44.5 $386,760 - $587,400	-13,200 Reduced 8.01%	151,600 $6.19 Million
Q1 2021 May 07, 2021	BUY	$30.8 - $39.51 $113,960 - $146,187	3,700 Added 2.3%	164,800 $5.59 Million
Q3 2020 Nov 09, 2020	BUY	$17.61 - $31.86 $475,470 - $860,220	27,000 Added 20.13%	161,100 $4.13 Million
Q2 2020 Aug 05, 2020	BUY	$14.35 - $26.64 $289,870 - $538,128	20,200 Added 17.73%	134,100 $3.44 Million
Q1 2020 May 08, 2020	BUY	$12.31 - $33.12 $297,902 - $801,503	24,200 Added 26.98%	113,900 $1.75 Million
Q4 2019 Feb 06, 2020	BUY	$7.26 - $38.49 $20,328 - $107,772	2,800 Added 3.22%	89,700 $3.08 Million
Q2 2019 Aug 02, 2019	BUY	$10.65 - $14.29 $75,615 - $101,459	7,100 Added 8.9%	86,900 $1.13 Million
Q1 2019 May 10, 2019	BUY	$10.9 - $14.09 $26,160 - $33,816	2,400 Added 3.1%	79,800 $972,000
Q4 2018 Feb 13, 2019	BUY	$10.36 - $20.96 $32,116 - $64,976	3,100 Added 4.17%	77,400 $882,000
Q1 2018 May 04, 2018	BUY	$15.16 - $25.49 $68,220 - $114,705	4,500 Added 6.45%	74,300 $1.56 Million
Q3 2017 Nov 03, 2017	BUY	$10.77 - $22.1 $751,746 - $1.54 Million	69,800	69,800 $1.1 Million

Others Institutions Holding ITCI

# of Institutions

378

Shares Held

84.7M

Call Options Held

319K

Put Options Held

143K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $8.17B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Intra Cellular Therapies, Inc. Transaction History